Answers are grounded in this paper and cite their sources.
Bone marrow failure in the pediatric patient places the hematologist at the junction of clinical medicine, cellular biology, and molecular genetics. The pathophysiology of these disorders is rapidly being elucidated in many laboratories. Treatments such as bone marrow transplantation and the nascent modality of gene therapy are firmly grounded in these modern sciences. This year's progress in the understanding, diagnosis, and treatment of a wide variety of predominantly pediatric bone marrow failure states is a direct result of the union between the "laboratory bench and the patient bedside."
No takes yet. Share an insight, caveat, or question.
Vlachos et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: